These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18650021)

  • 1. Strategies to control antipsychotic-induced weight gain.
    Kapoor S
    Psychoneuroendocrinology; 2008 Sep; 33(8):1171. PubMed ID: 18650021
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment: Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Hahn MK; Cohn T; Remington G
    Ann Pharmacother; 2010; 44(7-8):1349-50; author reply 1350-1. PubMed ID: 20587740
    [No Abstract]   [Full Text] [Related]  

  • 4. Practical Use of Pharmacotherapy for Obesity.
    Igel LI; Kumar RB; Saunders KH; Aronne LJ
    Gastroenterology; 2017 May; 152(7):1765-1779. PubMed ID: 28192104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate for reversing atypical antipsychotic weight gain.
    Lessig MC; Shapira NA; Murphy TK
    J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1364. PubMed ID: 11765278
    [No Abstract]   [Full Text] [Related]  

  • 6. Melatonin, Liraglutide, and Naltrexone/Bupropion for the Treatment of Obesity and Medication-Related Weight Gain.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2015 Jun; 53(6):19-22. PubMed ID: 26091546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate.
    Lin YH; Liu CY; Hsiao MC
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):613-5. PubMed ID: 16194268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia.
    Kim JH; Yim SJ; Nam JH
    Schizophr Res; 2006 Feb; 82(1):115-7. PubMed ID: 16326074
    [No Abstract]   [Full Text] [Related]  

  • 9. Gaining: pediatric patients and use of atypical antipsychotics.
    Towbin KE
    Am J Psychiatry; 2006 Dec; 163(12):2034-6. PubMed ID: 17151148
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review.
    Newall H; Myles N; Ward PB; Samaras K; Shiers D; Curtis J
    Int Clin Psychopharmacol; 2012 Mar; 27(2):69-75. PubMed ID: 21979790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine.
    Siskind D; Friend N; Russell A; McGrath JJ; Lim C; Patterson S; Flaws D; Stedman T; Moudgil V; Sardinha S; Suetani S; Kisely S; Winckel K; Baker A
    BMJ Open; 2018 Mar; 8(3):e021000. PubMed ID: 29500217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatment of obesity.
    Bray GA; Ryan DH
    Psychiatr Clin North Am; 2011 Dec; 34(4):871-80. PubMed ID: 22098810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Countering side effects.
    Oldham J
    J Psychiatr Pract; 2010 Sep; 16(5):285. PubMed ID: 20859105
    [No Abstract]   [Full Text] [Related]  

  • 14. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
    Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adjunctive use of metformin to treat or prevent atypical antipsychotic-induced weight gain: a review.
    Khan AY; Macaluso M; McHale RJ; Dahmen MM; Girrens K; Ali F
    J Psychiatr Pract; 2010 Sep; 16(5):289-96. PubMed ID: 20859106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy to limit weight gain caused by antipsychotic use.
    Malhi GS; Mitchell PB
    Expert Opin Pharmacother; 2003 Oct; 4(10):1679-86. PubMed ID: 14521478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of topiramate on weight gain in patients receiving atypical antipsychotic agents.
    Mahmood S; Booker I; Huang J; Coleman CI
    J Clin Psychopharmacol; 2013 Feb; 33(1):90-4. PubMed ID: 23277264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.
    de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R
    J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.
    Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP
    Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.